Single and Multiple Dose PK–PD Characterization for Carisoprodol. Part I: Pharmacokinetics, Metabolites, and 2C19 Phenotype Influence. Double-Blind, Placebo-Controlled Clinical Trial in Healthy Volunteers

  1. Calvo, A.
  2. Alonso, S.
  3. Prieto, E.
  4. Ascaso-Del-rio, A.
  5. Ortuño, J.
  6. Fernandez, N.
  7. Portolés, A.
Zeitschrift:
Journal of Clinical Medicine

ISSN: 2077-0383

Datum der Publikation: 2022

Ausgabe: 11

Nummer: 3

Art: Artikel

DOI: 10.3390/JCM11030858 GOOGLE SCHOLAR lock_openOpen Access editor